Different from any bird's nest product on the market in the past, GLYKEN drives Meili to wake up with scientific and technological innovation, further expands the imagination space of bird's nest health care, and has a brand-new definition in terms of nutrition upgrading and eating convenience, which is worthy of the name of the new category of "scientific bird's nest". It is reported that GLYKEN bird's nest peptide series products have been recognized by China Weightlifting Association, and become the official partner of China national weightlifting team and recommend bird's nest products. Some insiders have a hunch that bird's nest, a billion-dollar market that has been constantly questioned and pushed up, has entered a "great" big player, and people will wait and see whether it will become a "show" or a "subversive" in the bird's nest industry in the future.
Singapore Glacken Bird's Nest Industrial Chain Group with Strong Scientific Research Genes
According to official data, GLYKEN group was founded in Singapore in 20 10, and invested in the whole industrial chain of bird's nest for ten years. It not only owns the only bird's nest industrial park with independent property rights in Johor Strait, but also devotes itself to the innovation of bird's nest extraction biotechnology. It is the frontier institution of international bird's nest biological extraction and application research, and has established the only bird's nest extraction and application research center in the industry. Relevant scientific research achievements have been widely recognized in the field of biotechnology in Europe and America, and there are many fourth-generation bird's nest peptide products.
GLYKEN's research gene has been planted since its establishment. Mr. Shak Puishong, founder of GLYKEN Group, found that Malaysia and Indonesia, as the largest producers of bird's nest in the world, were deeply affected by poisonous bird's nest and fake bird's nest. At that time, the bird's nest industry in Malaysia was still a typical traditional industry with high labor costs, many primary products and low added value. The nutritional research of bird's nest has been blank for a long time, which makes bird's nest controversial. Mr. Sha Peixiong believes that only by embracing modern life science and letting the traditional bird's nest culture break the shackles of "oriental mysticism" can it adapt to the development of the times, break through cultural differences, be accepted by people all over the world and benefit all mankind.
On 20 1 1 year, Glacken cooperated with National University of Malaysia to establish Glacken Malaysia Bird's Nest Biological Laboratory to conduct a comprehensive study on the nutrition of bird's nest extract. After unremitting scientific research and experimental demonstration, GLYKEN developed a safe and effective technology for extracting protein and sialic acid from bird's nest into "active glycoprotein peptide". This "glycoprotein peptide" from bird's nest has a very significant health care effect on human body. Glycoprotein is a bridge for signal exchange and transmission of human cells, which plays an important role in promoting the replication of human stem cells, repairing damaged cells and promoting the repair of degenerative knee cartilage. These research results were published in American Biomedical Center 20 13, which is the first scientific research achievement in history to scientifically demonstrate the clinical efficacy of edible bird's nest.
The research results of GLYKEN laboratory are supported by the governments of Singapore and Malaysia. Glacken has successively cooperated with three famous universities, namely Malaysia Polytechnic University (UTM), National University of Malaysia (UKM) and National University of Singapore (NUS), to comprehensively develop bird's nest nutrition. Relying on the scientific research and technological advantages of three universities, GLYKEN bird's nest extraction technology has been transformed and applied, and scientific bird's nest has successfully achieved stable mass production.
20 million self-built China production line, the world's advanced bird's nest extraction technology production line settled in Guangxi Free Trade Zone.
As early as 202 1 and 1, Guangxi Free Trade Zone issued an official announcement, "Glacken Biological Products (Guangxi) Co., Ltd.; Ltd) officially passed the acceptance of China food safety supervision department, and obtained the production qualification of "scientific bird's nest peptide" in China. This marks that the world's leading GLYKEN patented bird's nest production line has been officially put into production in China.
Guangxi Bird's Nest Biotechnology is a wholly-owned subsidiary invested by Singapore GLYKEN Group. In April, 2020, Glacken Group entered Greater China, and introduced a set of mature patented technology and production system of bird's nest peptide extraction from abroad into China to ensure the consistency of the quality of Glacken's bird's nest peptide supplied worldwide. After three months' investigation, in August, 2020, we signed an investment agreement with Qinzhou Port Management Committee of China (Guangxi) Pilot Free Trade Zone, and chose to land in China-Malaysia Qinzhou Industrial Park, a Sino-Malaysia cooperation park.
The leaders of Guangxi Free Trade Zone attending the meeting said: "China-Malaysia Qinzhou Industrial Park is a dual-park transnational cooperation project jointly established by ASEAN trading partners China and Malaysia, and the bird's nest processing trade base is an important industrial project for China-Malaysia Qinzhou Industrial Park to promote international capacity cooperation and explore the Belt and Road. Glacken Group has the world-leading deep processing and extraction technology of bird's nest, and it is the only cutting-edge biotechnology enterprise in the bird's nest industry that takes bird's nest as raw material. The Glacken Group's settlement in Guangxi Free Trade Zone is a major achievement of China's Belt and Road economic and trade exchanges, which has effectively promoted the international capacity cooperation between China and Singapore in the field of big health. At the same time, for the Guangxi Free Trade Zone, Glacken has improved the biotechnology strength of the bird's nest processing and trade base, which is of great significance to the layout of Guangxi's scientific and healthy food industry. "
Scientific bird's nest brings a cool and healthy lifestyle and leads a new track for healthy food.
According to Ms. Huang, President of Glacken Greater China, "Glacken takes bird's nest as raw material, and scientifically fuses sialic acid from bird's nest with protein to extract" small glycoprotein peptide "which is easy to be absorbed and utilized by human body, greatly enhancing the nutritional value of bird's nest. It also empowers traditional industries through technological innovation, enhances industrial efficiency and makes the form of bird's nest more diversified. The official listing of GLYKEN brand indicates that GLYKEN will bring more nutritious, convenient, cost-effective and high-tech bird's nest products to consumers in China. It can be said that Glacken's bird's nest peptide redefines bird's nest and creatively combines China's traditional nourishing culture with modern biotechnology, bringing revolutionary new breakthroughs to the global bird's nest industry and bringing great health to mankind. "
Today, young people in China pay attention to health preservation, and the demand of Chinese people for high-quality products is obvious. At the same time, affected by consumption upgrading and COVID-19 epidemic, the iteration and innovation upgrading of health food industry are accelerating, and the nourishing health care industry represented by bird's nest has also ushered in the spring of development, and various brands have developed rapidly. On the road of chasing this new billion-dollar market, GLYKEN will bring unique patented technology and products to the market, or it will bring a new pattern to the bird's nest industry. We will wait and see.